APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mbbr Biomedia and Biochip

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mbbr Biomedia and Biochip Market Outlook and Growth Opportunities 2026

22 December 2025216 pages

Choose your research edition.

Industry ResearchMbbr Biomedia and Biochip Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Mbbr Biomedia and Biochip Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Mbbr Biomedia and Biochip Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mbbr Biomedia and Biochip Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Mbbr Biomedia and Biochip Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Mbbr Biomedia and Biochip market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mbbr Biomedia and Biochip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mbbr Biomedia and Biochip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mbbr Biomedia and Biochip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mbbr Biomedia and Biochip market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mbbr Biomedia and Biochip market include Thermo Fisher Scientific, PerkinElmer, Pingxiang City ZhongXing Packing, US Biomax, Transcend Cleantec, Sengenics, Paras Hydrotech, MUTAG A/S and IWE (Industrial Water Engineers (M) Sdn. Bhd.), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Mbbr Biomedia and Biochip market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mbbr Biomedia and Biochip and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mbbr Biomedia and Biochip revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mbbr Biomedia and Biochip market.

Mbbr Biomedia and Biochip Segment by Company

Thermo Fisher Scientific

PerkinElmer

Pingxiang City ZhongXing Packing

US Biomax

Transcend Cleantec

Sengenics

Paras Hydrotech

MUTAG A/S

IWE (Industrial Water Engineers (M) Sdn. Bhd.)

Illumina

Holly Technology

Fresh By Design (FBD)

FLI Water Limited

Enke Group

Ecologix Environmental Systems

DST Technology

Bio-Rad Laboratories

bioprocessH2O

BioChain

Applied Microarrays

Agilent Technologies

Mbbr Biomedia and Biochip Segment by Type

Mbbr Biomedia

Biochip

Mbbr Biomedia and Biochip Segment by Application

Laboratory Analysis

Industrial Bioprocessing

Others

Mbbr Biomedia and Biochip Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mbbr Biomedia and Biochip status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Mbbr Biomedia and Biochip key companies, revenue, market share, and recent developments.

3. To split the Mbbr Biomedia and Biochip breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Mbbr Biomedia and Biochip market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mbbr Biomedia and Biochip significant trends, drivers, influence factors in global and regions.

6. To analyze Mbbr Biomedia and Biochip competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mbbr Biomedia and Biochip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mbbr Biomedia and Biochip and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mbbr Biomedia and Biochip.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mbbr Biomedia and Biochip industry.

Chapter 3: Detailed analysis of Mbbr Biomedia and Biochip company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Mbbr Biomedia and Biochip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Mbbr Biomedia and Biochip in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mbbr Biomedia and Biochip Industry Trends Table 2. Mbbr Biomedia and Biochip Industry Drivers Table 3. Mbbr Biomedia and Biochip Industry Opportunities and Challenges Table 4. Mbbr Biomedia and Biochip Industry Restraints Table 5. Global Mbbr Biomedia and Biochip Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mbbr Biomedia and Biochip Revenue Share by Company (2021-2026) Table 7. Global Mbbr Biomedia and Biochip Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Mbbr Biomedia and Biochip Key Company Manufacturing Base & Headquarters Table 9. Global Mbbr Biomedia and Biochip Company, Product Type & Application Table 10. Global Mbbr Biomedia and Biochip Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Mbbr Biomedia and Biochip by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Mbbr Biomedia Table 15. Significant Companies of Biochip Table 16. Global Mbbr Biomedia and Biochip Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Mbbr Biomedia and Biochip Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Mbbr Biomedia and Biochip Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Mbbr Biomedia and Biochip Sales Value Share by Type (2021-2026) Table 20. Global Mbbr Biomedia and Biochip Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Laboratory Analysis Table 22. Significant Companies of Industrial Bioprocessing Table 23. Significant Companies of Others Table 24. Global Mbbr Biomedia and Biochip Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Mbbr Biomedia and Biochip Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Mbbr Biomedia and Biochip Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Mbbr Biomedia and Biochip Sales Value Share by Application (2021-2026) Table 28. Global Mbbr Biomedia and Biochip Sales Value Share by Application (2027-2032) Table 29. Global Mbbr Biomedia and Biochip Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Mbbr Biomedia and Biochip Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Mbbr Biomedia and Biochip Sales Value Share by Region (2021-2026) Table 32. Global Mbbr Biomedia and Biochip Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Mbbr Biomedia and Biochip Sales Value Share by Region (2027-2032) Table 34. Global Mbbr Biomedia and Biochip Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Mbbr Biomedia and Biochip Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Mbbr Biomedia and Biochip Sales Value Market Share by Country (2021-2026) Table 37. Global Mbbr Biomedia and Biochip Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Mbbr Biomedia and Biochip Sales Value Market Share by Country (2027-2032) Table 39. Thermo Fisher Scientific Company Information Table 40. Thermo Fisher Scientific Business Overview Table 41. Thermo Fisher Scientific Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Thermo Fisher Scientific Mbbr Biomedia and Biochip Product Portfolio Table 43. Thermo Fisher Scientific Recent Development Table 44. PerkinElmer Company Information Table 45. PerkinElmer Business Overview Table 46. PerkinElmer Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. PerkinElmer Mbbr Biomedia and Biochip Product Portfolio Table 48. PerkinElmer Recent Development Table 49. Pingxiang City ZhongXing Packing Company Information Table 50. Pingxiang City ZhongXing Packing Business Overview Table 51. Pingxiang City ZhongXing Packing Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Pingxiang City ZhongXing Packing Mbbr Biomedia and Biochip Product Portfolio Table 53. Pingxiang City ZhongXing Packing Recent Development Table 54. US Biomax Company Information Table 55. US Biomax Business Overview Table 56. US Biomax Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. US Biomax Mbbr Biomedia and Biochip Product Portfolio Table 58. US Biomax Recent Development Table 59. Transcend Cleantec Company Information Table 60. Transcend Cleantec Business Overview Table 61. Transcend Cleantec Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Transcend Cleantec Mbbr Biomedia and Biochip Product Portfolio Table 63. Transcend Cleantec Recent Development Table 64. Sengenics Company Information Table 65. Sengenics Business Overview Table 66. Sengenics Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sengenics Mbbr Biomedia and Biochip Product Portfolio Table 68. Sengenics Recent Development Table 69. Paras Hydrotech Company Information Table 70. Paras Hydrotech Business Overview Table 71. Paras Hydrotech Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Paras Hydrotech Mbbr Biomedia and Biochip Product Portfolio Table 73. Paras Hydrotech Recent Development Table 74. MUTAG A/S Company Information Table 75. MUTAG A/S Business Overview Table 76. MUTAG A/S Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. MUTAG A/S Mbbr Biomedia and Biochip Product Portfolio Table 78. MUTAG A/S Recent Development Table 79. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Company Information Table 80. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Business Overview Table 81. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Mbbr Biomedia and Biochip Product Portfolio Table 83. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Recent Development Table 84. Illumina Company Information Table 85. Illumina Business Overview Table 86. Illumina Mbbr Biomedia and Biochip Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Illumina Mbbr Biomedia and Biochip Product Portfolio Table 88. Illumina Recent Development Table 89. Holly Technology Company Information Table 90. Holly Technology Business Overview Table 91. Holly Technology Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Holly Technology Mbbr Biomedia and Biochip Product Portfolio Table 93. Holly Technology Recent Development Table 94. Fresh By Design (FBD) Company Information Table 95. Fresh By Design (FBD) Business Overview Table 96. Fresh By Design (FBD) Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Fresh By Design (FBD) Mbbr Biomedia and Biochip Product Portfolio Table 98. Fresh By Design (FBD) Recent Development Table 99. FLI Water Limited Company Information Table 100. FLI Water Limited Business Overview Table 101. FLI Water Limited Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. FLI Water Limited Mbbr Biomedia and Biochip Product Portfolio Table 103. FLI Water Limited Recent Development Table 104. Enke Group Company Information Table 105. Enke Group Business Overview Table 106. Enke Group Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. Enke Group Mbbr Biomedia and Biochip Product Portfolio Table 108. Enke Group Recent Development Table 109. Ecologix Environmental Systems Company Information Table 110. Ecologix Environmental Systems Business Overview Table 111. Ecologix Environmental Systems Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. Ecologix Environmental Systems Mbbr Biomedia and Biochip Product Portfolio Table 113. Ecologix Environmental Systems Recent Development Table 114. DST Technology Company Information Table 115. DST Technology Business Overview Table 116. DST Technology Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. DST Technology Mbbr Biomedia and Biochip Product Portfolio Table 118. DST Technology Recent Development Table 119. Bio-Rad Laboratories Company Information Table 120. Bio-Rad Laboratories Business Overview Table 121. Bio-Rad Laboratories Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 122. Bio-Rad Laboratories Mbbr Biomedia and Biochip Product Portfolio Table 123. Bio-Rad Laboratories Recent Development Table 124. bioprocessH2O Company Information Table 125. bioprocessH2O Business Overview Table 126. bioprocessH2O Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 127. bioprocessH2O Mbbr Biomedia and Biochip Product Portfolio Table 128. bioprocessH2O Recent Development Table 129. BioChain Company Information Table 130. BioChain Business Overview Table 131. BioChain Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 132. BioChain Mbbr Biomedia and Biochip Product Portfolio Table 133. BioChain Recent Development Table 134. Applied Microarrays Company Information Table 135. Applied Microarrays Business Overview Table 136. Applied Microarrays Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 137. Applied Microarrays Mbbr Biomedia and Biochip Product Portfolio Table 138. Applied Microarrays Recent Development Table 139. Agilent Technologies Company Information Table 140. Agilent Technologies Business Overview Table 141. Agilent Technologies Mbbr Biomedia and Biochip Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 142. Agilent Technologies Mbbr Biomedia and Biochip Product Portfolio Table 143. Agilent Technologies Recent Development Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Mbbr Biomedia and Biochip Product Image Figure 2. Global Mbbr Biomedia and Biochip Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mbbr Biomedia and Biochip Market Size (2021-2032) & (US$ Million) Figure 4. Global Mbbr Biomedia and Biochip Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Mbbr Biomedia Image Figure 8. Biochip Image Figure 9. Global Mbbr Biomedia and Biochip Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Mbbr Biomedia and Biochip Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Mbbr Biomedia and Biochip Sales Value Share by Type (2021-2032) Figure 12. Laboratory Analysis Image Figure 13. Industrial Bioprocessing Image Figure 14. Others Image Figure 15. Global Mbbr Biomedia and Biochip Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Mbbr Biomedia and Biochip Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Mbbr Biomedia and Biochip Sales Value Share by Application (2021-2032) Figure 18. Global Mbbr Biomedia and Biochip Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Mbbr Biomedia and Biochip Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Mbbr Biomedia and Biochip Sales Value (2021-2032) & (US$ Million) Figure 21. North America Mbbr Biomedia and Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Mbbr Biomedia and Biochip Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Mbbr Biomedia and Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Mbbr Biomedia and Biochip Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Mbbr Biomedia and Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Mbbr Biomedia and Biochip Sales Value (2021-2032) & (US$ Million) Figure 27. South America Mbbr Biomedia and Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Mbbr Biomedia and Biochip Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Mbbr Biomedia and Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Mbbr Biomedia
  • Biochip
Applications
  • Laboratory Analysis
  • Industrial Bioprocessing
  • Others
Companies covered
  • Thermo Fisher Scientific
  • PerkinElmer
  • Pingxiang City ZhongXing Packing
  • US Biomax
  • Transcend Cleantec
  • Sengenics
  • Paras Hydrotech
  • MUTAG A/S
  • IWE (Industrial Water Engineers (M) Sdn. Bhd.)
  • Illumina
  • Holly Technology
  • Fresh By Design (FBD)
  • FLI Water Limited
  • Enke Group
  • Ecologix Environmental Systems
  • DST Technology
  • Bio-Rad Laboratories
  • bioprocessH2O
  • BioChain
  • Applied Microarrays
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mbbr Biomedia and Biochip Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mbbr Biomedia and Biochip Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Mbbr Biomedia and Biochip Market Dynamics
  1. 2.1 Mbbr Biomedia and Biochip Industry Trends
  2. 2.2 Mbbr Biomedia and Biochip Industry Drivers
  3. 2.3 Mbbr Biomedia and Biochip Industry Opportunities and Challenges
  4. 2.4 Mbbr Biomedia and Biochip Industry Restraints
3 Mbbr Biomedia and Biochip Market by Company
  1. 3.1 Global Mbbr Biomedia and Biochip Company Revenue Ranking in 2025
  2. 3.2 Global Mbbr Biomedia and Biochip Revenue by Company (2021-2026)
  3. 3.3 Global Mbbr Biomedia and Biochip Company Ranking (2024-2026)
  4. 3.4 Global Mbbr Biomedia and Biochip Company Manufacturing Base and Headquarters
  5. 3.5 Global Mbbr Biomedia and Biochip Company Product Type and Application
  6. 3.6 Global Mbbr Biomedia and Biochip Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Mbbr Biomedia and Biochip Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Mbbr Biomedia and Biochip Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Mbbr Biomedia and Biochip Market by Type
  1. 4.1 Mbbr Biomedia and Biochip Type Introduction
  2. 4.1.1 Mbbr Biomedia
  3. 4.1.2 Biochip
  4. 4.2 Global Mbbr Biomedia and Biochip Sales Value by Type
  5. 4.2.1 Global Mbbr Biomedia and Biochip Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mbbr Biomedia and Biochip Sales Value by Type (2021-2032)
  7. 4.2.3 Global Mbbr Biomedia and Biochip Sales Value Share by Type (2021-2032)
5 Mbbr Biomedia and Biochip Market by Application
  1. 5.1 Mbbr Biomedia and Biochip Application Introduction
  2. 5.1.1 Laboratory Analysis
  3. 5.1.2 Industrial Bioprocessing
  4. 5.1.3 Others
  5. 5.2 Global Mbbr Biomedia and Biochip Sales Value by Application
  6. 5.2.1 Global Mbbr Biomedia and Biochip Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mbbr Biomedia and Biochip Sales Value by Application (2021-2032)
  8. 5.2.3 Global Mbbr Biomedia and Biochip Sales Value Share by Application (2021-2032)
6 Mbbr Biomedia and Biochip Regional Value Analysis
  1. 6.1 Global Mbbr Biomedia and Biochip Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mbbr Biomedia and Biochip Sales Value by Region (2021-2032)
  3. 6.2.1 Global Mbbr Biomedia and Biochip Sales Value by Region: 2021-2026
  4. 6.2.2 Global Mbbr Biomedia and Biochip Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mbbr Biomedia and Biochip Sales Value (2021-2032)
  7. 6.3.2 North America Mbbr Biomedia and Biochip Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Mbbr Biomedia and Biochip Sales Value (2021-2032)
  10. 6.4.2 Europe Mbbr Biomedia and Biochip Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Mbbr Biomedia and Biochip Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Mbbr Biomedia and Biochip Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Mbbr Biomedia and Biochip Sales Value (2021-2032)
  16. 6.6.2 South America Mbbr Biomedia and Biochip Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Mbbr Biomedia and Biochip Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Mbbr Biomedia and Biochip Sales Value Share by Country, 2025 VS 2032
7 Mbbr Biomedia and Biochip Country-level Value Analysis
  1. 7.1 Global Mbbr Biomedia and Biochip Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mbbr Biomedia and Biochip Sales Value by Country (2021-2032)
  3. 7.2.1 Global Mbbr Biomedia and Biochip Sales Value by Country (2021-2026)
  4. 7.2.2 Global Mbbr Biomedia and Biochip Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Mbbr Biomedia and Biochip Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Mbbr Biomedia and Biochip Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Mbbr Biomedia and Biochip Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Mbbr Biomedia and Biochip Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 PerkinElmer
  8. 8.2.1 PerkinElmer Company Information
  9. 8.2.2 PerkinElmer Business Overview
  10. 8.2.3 PerkinElmer Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PerkinElmer Mbbr Biomedia and Biochip Product Portfolio
  12. 8.2.5 PerkinElmer Recent Developments
  13. 8.3 Pingxiang City ZhongXing Packing
  14. 8.3.1 Pingxiang City ZhongXing Packing Company Information
  15. 8.3.2 Pingxiang City ZhongXing Packing Business Overview
  16. 8.3.3 Pingxiang City ZhongXing Packing Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pingxiang City ZhongXing Packing Mbbr Biomedia and Biochip Product Portfolio
  18. 8.3.5 Pingxiang City ZhongXing Packing Recent Developments
  19. 8.4 US Biomax
  20. 8.4.1 US Biomax Company Information
  21. 8.4.2 US Biomax Business Overview
  22. 8.4.3 US Biomax Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  23. 8.4.4 US Biomax Mbbr Biomedia and Biochip Product Portfolio
  24. 8.4.5 US Biomax Recent Developments
  25. 8.5 Transcend Cleantec
  26. 8.5.1 Transcend Cleantec Company Information
  27. 8.5.2 Transcend Cleantec Business Overview
  28. 8.5.3 Transcend Cleantec Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Transcend Cleantec Mbbr Biomedia and Biochip Product Portfolio
  30. 8.5.5 Transcend Cleantec Recent Developments
  31. 8.6 Sengenics
  32. 8.6.1 Sengenics Company Information
  33. 8.6.2 Sengenics Business Overview
  34. 8.6.3 Sengenics Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sengenics Mbbr Biomedia and Biochip Product Portfolio
  36. 8.6.5 Sengenics Recent Developments
  37. 8.7 Paras Hydrotech
  38. 8.7.1 Paras Hydrotech Company Information
  39. 8.7.2 Paras Hydrotech Business Overview
  40. 8.7.3 Paras Hydrotech Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Paras Hydrotech Mbbr Biomedia and Biochip Product Portfolio
  42. 8.7.5 Paras Hydrotech Recent Developments
  43. 8.8 MUTAG A/S
  44. 8.8.1 MUTAG A/S Company Information
  45. 8.8.2 MUTAG A/S Business Overview
  46. 8.8.3 MUTAG A/S Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MUTAG A/S Mbbr Biomedia and Biochip Product Portfolio
  48. 8.8.5 MUTAG A/S Recent Developments
  49. 8.9 IWE (Industrial Water Engineers (M) Sdn. Bhd.)
  50. 8.9.1 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Company Information
  51. 8.9.2 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Business Overview
  52. 8.9.3 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Mbbr Biomedia and Biochip Product Portfolio
  54. 8.9.5 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Recent Developments
  55. 8.10 Illumina
  56. 8.10.1 Illumina Company Information
  57. 8.10.2 Illumina Business Overview
  58. 8.10.3 Illumina Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Illumina Mbbr Biomedia and Biochip Product Portfolio
  60. 8.10.5 Illumina Recent Developments
  61. 8.11 Holly Technology
  62. 8.11.1 Holly Technology Company Information
  63. 8.11.2 Holly Technology Business Overview
  64. 8.11.3 Holly Technology Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Holly Technology Mbbr Biomedia and Biochip Product Portfolio
  66. 8.11.5 Holly Technology Recent Developments
  67. 8.12 Fresh By Design (FBD)
  68. 8.12.1 Fresh By Design (FBD) Company Information
  69. 8.12.2 Fresh By Design (FBD) Business Overview
  70. 8.12.3 Fresh By Design (FBD) Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fresh By Design (FBD) Mbbr Biomedia and Biochip Product Portfolio
  72. 8.12.5 Fresh By Design (FBD) Recent Developments
  73. 8.13 FLI Water Limited
  74. 8.13.1 FLI Water Limited Company Information
  75. 8.13.2 FLI Water Limited Business Overview
  76. 8.13.3 FLI Water Limited Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  77. 8.13.4 FLI Water Limited Mbbr Biomedia and Biochip Product Portfolio
  78. 8.13.5 FLI Water Limited Recent Developments
  79. 8.14 Enke Group
  80. 8.14.1 Enke Group Company Information
  81. 8.14.2 Enke Group Business Overview
  82. 8.14.3 Enke Group Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Enke Group Mbbr Biomedia and Biochip Product Portfolio
  84. 8.14.5 Enke Group Recent Developments
  85. 8.15 Ecologix Environmental Systems
  86. 8.15.1 Ecologix Environmental Systems Company Information
  87. 8.15.2 Ecologix Environmental Systems Business Overview
  88. 8.15.3 Ecologix Environmental Systems Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ecologix Environmental Systems Mbbr Biomedia and Biochip Product Portfolio
  90. 8.15.5 Ecologix Environmental Systems Recent Developments
  91. 8.16 DST Technology
  92. 8.16.1 DST Technology Company Information
  93. 8.16.2 DST Technology Business Overview
  94. 8.16.3 DST Technology Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  95. 8.16.4 DST Technology Mbbr Biomedia and Biochip Product Portfolio
  96. 8.16.5 DST Technology Recent Developments
  97. 8.17 Bio-Rad Laboratories
  98. 8.17.1 Bio-Rad Laboratories Company Information
  99. 8.17.2 Bio-Rad Laboratories Business Overview
  100. 8.17.3 Bio-Rad Laboratories Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bio-Rad Laboratories Mbbr Biomedia and Biochip Product Portfolio
  102. 8.17.5 Bio-Rad Laboratories Recent Developments
  103. 8.18 bioprocessH2O
  104. 8.18.1 bioprocessH2O Company Information
  105. 8.18.2 bioprocessH2O Business Overview
  106. 8.18.3 bioprocessH2O Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  107. 8.18.4 bioprocessH2O Mbbr Biomedia and Biochip Product Portfolio
  108. 8.18.5 bioprocessH2O Recent Developments
  109. 8.19 BioChain
  110. 8.19.1 BioChain Company Information
  111. 8.19.2 BioChain Business Overview
  112. 8.19.3 BioChain Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  113. 8.19.4 BioChain Mbbr Biomedia and Biochip Product Portfolio
  114. 8.19.5 BioChain Recent Developments
  115. 8.20 Applied Microarrays
  116. 8.20.1 Applied Microarrays Company Information
  117. 8.20.2 Applied Microarrays Business Overview
  118. 8.20.3 Applied Microarrays Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Applied Microarrays Mbbr Biomedia and Biochip Product Portfolio
  120. 8.20.5 Applied Microarrays Recent Developments
  121. 8.21 Agilent Technologies
  122. 8.21.1 Agilent Technologies Company Information
  123. 8.21.2 Agilent Technologies Business Overview
  124. 8.21.3 Agilent Technologies Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Agilent Technologies Mbbr Biomedia and Biochip Product Portfolio
  126. 8.21.5 Agilent Technologies Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst